Signaturefd LLC Acquires 133 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Signaturefd LLC boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.4% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 3,155 shares of the company’s stock after buying an additional 133 shares during the quarter. Signaturefd LLC’s holdings in HCA Healthcare were worth $1,282,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently added to or reduced their stakes in HCA. Bangor Savings Bank lifted its holdings in HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC purchased a new position in HCA Healthcare during the second quarter valued at approximately $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare during the second quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC lifted its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new position in shares of HCA Healthcare in the second quarter worth $33,000. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. UBS Group boosted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Royal Bank of Canada boosted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Oppenheimer upped their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Finally, Wells Fargo & Company upped their price target on shares of HCA Healthcare from $365.00 to $395.00 and gave the company an “equal weight” rating in a research note on Tuesday. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $367.15.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,345 shares of company stock worth $5,747,945 in the last three months. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Up 0.5 %

NYSE HCA opened at $410.03 on Thursday. The company’s 50-day moving average price is $394.72 and its 200-day moving average price is $352.30. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market cap of $107.39 billion, a PE ratio of 20.44, a PEG ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same period in the prior year, the business posted $4.29 earnings per share. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. Equities research analysts forecast that HCA Healthcare, Inc. will post 22.51 earnings per share for the current year.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.